Two Sigma Advisers’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $3.5M | Buy |
|
|||||
|
2025
Q3 | $857K | Buy |
|
|||||
|
2025
Q2 | $228K | Sell |
|
|||||
|
2025
Q1 | $1.22M | Buy |
|
|||||
|
2024
Q4 | $328K | Buy |
|
|||||
|
2024
Q3 | $401K | Sell |
|
|||||
|
2024
Q2 | $813K | Buy |
|
|||||
|
2024
Q1 | $947K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $744K | Buy |
|
|||||
|
2021
Q2 | $319K | Buy |
|
|||||
|
2021
Q1 | $277K | Buy |
|